Argent Biopharma Limited has released a press release.
MGC Pharma Launches Share Purchase Plan
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- MGC receives permission for first import of Psilocybin
- Commitments Received for GBP 0.7m
- AMC Places Second Order of ArtemiC for US$1M
- Malta Production Facility Receives EU-GMP Approval
- Fundraise closed raising up to a total of GBP 2.09m
Later from Argent Biopharma
- Pre-clinical Trial Results on CimetrA
- Share Purchase Plan Closed
- Pause in trading
- Retraction of Statement
- Company Update & Capital Raising
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma